Home › Funds › AMI ASSET MANAGEMENT CORP › VRTX
AMI ASSET MANAGEMENT CORP position in VRTX
VERTEX PHARMACEUTICALS INC · Health Care
AMI ASSET MANAGEMENT CORP reported holding 66,949 shares of VRTX (VERTEX PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$35.0M, representing 2.22% of its reported portfolio and ranking #23 among its reported holdings. AMI ASSET MANAGEMENT CORP first reported this position in Q3 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How AMI ASSET MANAGEMENT CORP's VRTX position evolved
AMI ASSET MANAGEMENT CORP first disclosed a stake in VRTX in Q3 2026 at 66,949 shares (US$35.0M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 66.95K | $35.00M | New |
About VRTX and 13F data
VRTX (VERTEX PHARMACEUTICALS INC) is a Health Care company. 32 other funds we track also report a position in VRTX — the largest reported positions include Capital World Investors (US$13.58B), Capital World Investors (US$12.97B), Capital Research Global Investors (US$9.68B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding VRTX
- Capital World Investors 25.97M sh · $13.58B · Q3 2026
- Capital World Investors 26.12M sh · $12.97B · Q2 2026
- Capital Research Global Investors 19.49M sh · $9.68B · Q2 2026
- Capital Research Global Investors 17.81M sh · $9.31B · Q3 2026
- Invesco Ltd 8.28M sh · $4.33B · Q3 2026
- Capital International Investors 5.06M sh · $2.65B · Q3 2026
- Franklin Resources 4.46M sh · $2.45B · Q3 2026
- LOOMIS SAYLES & CO L P 3.62M sh · $1.89B · Q3 2026
- JENNISON ASSOCIATES LLC 3.00M sh · $1.49B · Q2 2026
- ALLIANCEBERNSTEIN L.P. 3.02M sh · $1.35B · Q2 2026
- VICTORY CAPITAL MANAGEMENT INC 2.56M sh · $1.34B · Q3 2026
- Janus Henderson Group 2.13M sh · $951.79M · Q1 2026
More on AMI ASSET MANAGEMENT CORP
FAQ
How long has AMI ASSET MANAGEMENT CORP held VRTX?
AMI ASSET MANAGEMENT CORP has disclosed VRTX holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is AMI ASSET MANAGEMENT CORP's current position in VRTX?
As of Q3 2026, AMI ASSET MANAGEMENT CORP holds 66.95K shares of VRTX (VERTEX PHARMACEUTICALS INC), valued at $35.00M, representing 2.22% of its reported portfolio and ranking #23.
Has AMI ASSET MANAGEMENT CORP been buying or selling VRTX?
In the latest 13F filing (Q3 2026), AMI ASSET MANAGEMENT CORP newly opened its position in VRTX.
Which other funds hold VRTX?
Other major institutional holders of VRTX include Capital World Investors, Capital World Investors, Capital Research Global Investors, among 32 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.